
Women's Health
Latest News
Latest Videos

Shorts


Podcasts
CME Content
More News

This FAQ describes what oncology pharmacists should know ahead of Gynecologic Cancer Awareness Month in September.

If Heidi Overton is confirmed, the FDA nominee's views on abortion pills, vaccines, and drug review could reshape pharmacists' daily work.

OTC Norgestrel Widens Access as Pharmacists Guide Use
New data show Opill reaches uninsured, rural, and younger patients—putting pharmacists at the center of daily dosing counseling.

New data link T2DM and prediabetes to more numerous, more severe symptoms, especially postmenopause.

A 61,000-woman Danish cohort found overweight or obesity trajectories from 6 years of age tracked with lower odds of childbirth by the mid-20s.

Every additional access point—a pharmacist trained to screen, counsel, and, where authorized, initiate or manage therapy—is a smaller referral bottleneck.

Pharmacists are well positioned to clear the confusion on treatments for menopause through evidence-based counseling and individualized symptom management.

FDA-cleared HPV self-collection kits like Teal Wand expand cervical cancer screening; pharmacists support follow-up, HPV education, and Gardasil.

As options expand, pharmacists play an increasingly important role in working collaboratively with prescribers and patients to deliver individualized, evidence-based care.

A new toxicological risk assessment builds on 2024 findings that raised consumer concern, offering pharmacists reassuring data to share with patients.

Physicians oversee prescription medications the patient is taking, but OTC products bypass this system, and patients are often unaware of what can and cannot be taken.

Danish study links meningioma risk to progestogen contraceptives, including injectable depot medroxyprogesterone acetate and levonorgestrel intrauterine devices.

PCOS becomes PMOS, spotlighting metabolic and endocrine risks.

At ACTHIV 2026, Jaimee Colvin, MSN, APRN, FNP-C, outlined how provider knowledge gaps, entrenched stigma, and a lack of culturally representative outreach continue to drive the PrEP disparity among cisgender Black and Brown women.

What began as a modest survey has grown into one of the most trusted barometers of frontline pharmaceutical expertise in the country.

A post hoc analysis of ATTAIN-1 and ATTAIN-2 presented at ADA 2026 found orforglipron (Foundayo) significantly reduced body weight and waist circumference in women regardless of menopausal stage.

Clinical pharmacists may play an increasingly important role in longitudinal metabolic care, medication optimization, patient education, and multidisciplinary peptide management.

The ruling comes after weeks of uncertainty for patients, health care providers, and pharmacists about how and whether they could access and distribute the drug.

Pharmacists can guide the appropriate use of nonprescription therapies, reinforce recommended prevention strategies, and encourage patients to seek medical evaluation when warranted.

PMOS to replace PCOS, highlighting metabolic and endocrine roots and a 3-year global rollout aimed at faster diagnosis and better care.

Discover how pharmacists guide women through sensitive health needs, improving outcomes in every community.
























































































































